MAPT and Cognitive impairment: This study provides experimental evidence for the delayed treatment of diseases mainly manifested as hyperphosphorylation of tau, such as CTE, TBI, and frontotemporal dementia, which may better control the progress of the diseases and offer new insight into cognitive impairment.